Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 3/20 | 0.61 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.61 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.61 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.59 |
| ▸ | XDH | P47989 | 1/20 | 0.56 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.56 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.54 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.54 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.51 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.50 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425207 | 1.00 | GABRG2 (0.61) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL18411383 | 0.98 | GABRG2 (0.59) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL18411368 | 0.98 | GABRG2 (0.59) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL27787243 | 0.95 | CLK4 (0.63) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL20396126 | 0.94 | XDH (0.56) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL29511815 | 0.94 | XDH (0.56) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| Biphenyl SCHEMBL29234256 | 0.93 | TSHR (0.62) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| Hydrochloric Acid SCHEMBL28007259 | 0.93 | CLK4 (0.61) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL2154026 | 0.93 | CLK4 (0.65) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| Phenol SCHEMBL28023686 | 0.90 | XDH (0.57) | GABRG2GABRB3GABRA5GABRA3GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240423011-A1 | PLANAR LIGHT-EMITTING TRANSISTOR DEVICE CAPABLE OF SURFACE LIGHT SOURCE EMISSION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2024-12-19 | — | — | US | claimed |
| CN-113024530-B | Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof | 合肥工业大学 | 2023-07-18 | — | — | CN | claimed |
| WO-2023078156-A1 | PLANAR LIGHT-EMITTING TRANSISTOR DEVICE CAPABLE OF SURFACE LIGHT SOURCE EMISSION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国科学院化学研究所 | 2023-05-11 | — | — | WO | claimed |
| CN-113594378-A | Light emitting layer material, light emitting device, and light emitting apparatus | 广东聚华印刷显示技术有限公司 | 2021-11-02 | — | — | CN | claimed |
| CN-113024530-A | Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof | 合肥工业大学 | 2021-06-25 | — | — | CN | claimed |
| CN-111883676-A | Electroluminescent device and display device | 广东聚华印刷显示技术有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-111883677-A | Hybrid light emitting device and display apparatus | 广东聚华印刷显示技术有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-111883678-A | Electroluminescent device and display device | 广东聚华印刷显示技术有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-108863894-B | Method for directly synthesizing indole from nitrile | 中国科学技术大学 | 2020-08-14 | — | — | CN | claimed |
| CN-105102449-B | Antiviral compound | 豪夫迈·罗氏有限公司 | 2017-06-13 | — | — | CN | claimed |
| EP-1667958-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033063-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| EP-1509497-A1 | CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES | Amgen Inc. (US) | 2005-03-02 | — | — | EP | claimed |
| CN-1498218-A | Imidazo-pyrimidine derivatives as GABA receptor ligands | Ĭ�ˡ�����-��ķ��˾ | 2004-05-19 | — | — | CN | claimed |
| CN-1487924-A | Farnesyl transferase inhibitors | ���Ͽع�����˾ | 2004-04-07 | — | — | CN | claimed |
| WO-2003099776-A1 | CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES | AMGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| EP-1339695-A1 | FARNESYLTRANSFERASE INHIBITORS | Abbott Laboratories (US) | 2003-09-03 | — | — | EP | claimed |
| WO-2002074747-A1 | FARNESYLTRANSFERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2002-09-26 | — | — | WO | claimed |
| EP-0913725-A1 | Optically adressed spatial light modulator with a polymeric-liquid crystal structure | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1999-05-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | GABRG2 422/4885GABRB3 389/4885GABRA5 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.